
Embecta Corp.
EMBCNasdaqCIK 1872789HealthcareFiscal year ends Sep 30
Reports and events: 63 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-12-2006:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-22-000019 |
| 2022-09-3016:11 ET | 8-K | 8.01 Other events | 0000947871-22-001036 |
| 2022-08-1512:50 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001872789-22-000015 |
| 2022-08-1506:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-22-000013 |
| 2022-05-1312:34 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001872789-22-000009 |
| 2022-05-1307:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001872789-22-000007 |
| 2022-04-0616:57 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-097622 |
| 2022-03-2416:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-083889 |
| 2022-03-2307:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-082093 |
| 2022-03-1611:31 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001193125-22-076942 |
| 2022-03-0708:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-067116 |
| 2022-03-0416:01 ET | 8-K | 5.04 Item not in the standard list | 0001193125-22-066045 |
| 2022-02-1108:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-035814 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.